Corcept Therapeutics Incorporated (NASDAQ:CORT) Shows Short-Term Momentum But Overvalued; Near-Term Pullback Likely
![]() |
Momentum indicators present mixed but fragile upside while valuations remain stretched versus fundamentals and analyst targets. Short-term rallies may encounter selling pressure given elevated valuation and recent regulatory headlines. |








